World News: 12:30 GMT Monday 12th February 2018. [Immunomic Therapeutics (ITI) via Businesswire via SPi World News]
Immunomic Therapeutics ITI pioneering the study of investigational LAMP-based nucleic acid immunotherapy programs, announced today that the company will participate at the 2018 BIO CEO Investor Conference in two events:...
Business Wire: 12:30 GMT Monday 12th February 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.